searcher

U.S. Healthcare Legislation Investment Impact

Those enterprises that will profit from any increase in volume in patients and procedures would be the most likely to benefit. Abbott Labs, Covidien, Becton, Dicknson, C.R. Bard, Baxter Int'l etc.. Also, well capitalized generic drug makers. It's an ill wind that blows no one any good.

12 Stocks in Focus for the Obama Era

"..besides what the President of the United States likes best." No kidding. I'm not letting my currently affronted ideological leanings be leveraged by some of the Chicken Littles out there in the economic and political barnyard. Don't let the posturing of those whose bread and butter is the marketing of an 'attitude' sway cool investment judgement. Investment is intended to generate a return and not to make a 'statement'.

Cramer's Mad Money - Obama's Revenge (3/5/09)

Perfection is the nemesis of success. Didn't vote for Obama and not likely to but wish success for him to the extent the economy can be revived. However, fear Pelosi et al view this emergency as an opportunity to cram 'progressive', as in irrelevant if not counter-productive, policies down our throats.

Health Benefit Provider Stocks Seriously Ailing

Universal 'coverage' and its subset pre-existing condition coverage will be to health 'insurance' as SSI is to 'insurance', excepting no pretense of a self selecting pool is attempted. Those business plans best best able to administer politically necessitated triage will prosper, the others will waste away.